Nicotine replacement therapy market to reach $4.54 billion by 2030 at 5.6% cagr, driven by rising incidence of smoking-related diseases.
Read More
Nicotine addiction treatment market to reach $6.21 billion by 2030 at 10.1% cagr, driven by rising prevalence of tobacco addiction among teenagers.
Read More
Next generation tissue biomarkers market to reach $5.51 billion by 2030 at 12.6% cagr, driven by rising demand for personalized medicine.
Read More
Next generation drug conjugates market to reach $5.1 billion by 2030 at 15.7% cagr, driven by rising prevalence of cancer.
Read More
Next generation complement therapeutics market to reach $15.29 billion by 2030 at 15.6% cagr, driven by rise in prevalence of chronic diseases.
Read More
Next generation antibody drug market to reach $33.53 billion by 2030 at 15.4% cagr, driven by increasing focus on personalized medicine.
Read More
Nexletol market to reach $6.07 billion by 2030 at 13.5% cagr, driven by increasing cases of cardiovascular diseases.
Read More
Neutropenia biologic drug treatment market to reach $20.88 billion by 2030 at 7.2% cagr, driven by rise in number of cancer cases globally.
Read More
Neutralizing antibody market to reach $447.16 billion by 2030 at 11.6% cagr, driven by rising prevalence of infectious diseases.
Read More
Neurotoxin-inspired peptide market to reach $2.31 billion by 2030 at 13.5% cagr, driven by rising prevalence of neurological disorders.
Read More